Mangoceuticals, Inc.
MGRX
$1.11
$0.043.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.67% | -11.91% | -148.38% | 2.54% | 16.39% |
| Total Depreciation and Amortization | -97.03% | 101.49% | -42.50% | 2,588.97% | -189.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -292.18% | 8.49% |
| Total Other Non-Cash Items | 111.28% | 62.16% | 292.23% | -17.06% | -30.31% |
| Change in Net Operating Assets | -577.96% | -39.39% | 196.12% | 481.72% | 102.92% |
| Cash from Operations | 1.20% | 44.77% | -101.38% | 3.11% | 26.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -100.00% |
| Total Debt Issued | -100.00% | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -6.31% | 52.49% | 49.34% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 187.50% | -46.67% | -50.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 26.61% | -43.95% | 103.56% | 49.67% | -62.28% |
| Foreign Exchange rate Adjustments | -100.00% | -97.37% | 192.68% | -1,540.00% | 54.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,452.24% | 37.64% | 216.34% | 96.32% | -187.66% |